WallStSmart

Medtronic PLC (MDT)vsTalen Energy Corporation (TLN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medtronic PLC generates 955% more annual revenue ($35.48B vs $3.37B). MDT leads profitability with a 13.0% profit margin vs -0.6%. MDT earns a higher WallStSmart Score of 58/100 (C).

MDT

Buy

58

out of 100

Grade: C

Growth: 4.0Profit: 6.5Value: 6.7Quality: 5.0

TLN

Hold

48

out of 100

Grade: D+

Growth: 8.0Profit: 4.0Value: 4.0Quality: 5.3
Piotroski: 4/9Altman Z: 0.70
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDTUndervalued (+27.7%)

Margin of Safety

+27.7%

Fair Value

$107.79

Current Price

$76.15

$31.64 discount

UndervaluedFair: $107.79Overvalued
TLNSignificantly Overvalued (-76.5%)

Margin of Safety

-76.5%

Fair Value

$200.88

Current Price

$386.37

$185.49 premium

UndervaluedFair: $200.88Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDT4 strengths · Avg: 8.3/10
Market CapQuality
$100.09B9/10

Large-cap with strong market position

Price/BookValuation
2.0x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.0%8/10

Strong operational efficiency at 20.0%

Free Cash FlowQuality
$2.30B8/10

Generating 2.3B in free cash flow

TLN2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
78.9%10/10

Revenue surging 78.9% year-over-year

EPS GrowthGrowth
34.5%8/10

Earnings expanding 34.5% YoY

Areas to Watch

MDT1 concerns · Avg: 2.0/10
EPS GrowthGrowth
-11.8%2/10

Earnings declined 11.8%

TLN4 concerns · Avg: 2.3/10
Price/BookValuation
16.2x4/10

Trading at 16.2x book value

Return on EquityProfitability
-1.9%2/10

ROE of -1.9% — below average capital efficiency

Altman Z-ScoreHealth
0.702/10

Distress zone — elevated risk

Profit MarginProfitability
-0.6%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : MDT

The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin. PEG of 1.36 suggests the stock is reasonably priced for its growth.

Bull Case : TLN

The strongest argument for TLN centers on Revenue Growth, EPS Growth. Revenue growth of 78.9% demonstrates continued momentum.

Bear Case : MDT

The primary concerns for MDT are EPS Growth.

Bear Case : TLN

The primary concerns for TLN are Price/Book, Return on Equity, Altman Z-Score.

Key Dynamics to Monitor

MDT profiles as a value stock while TLN is a hypergrowth play — different risk/reward profiles.

TLN carries more volatility with a beta of 1.67 — expect wider price swings.

TLN is growing revenue faster at 78.9% — sustainability is the question.

MDT generates stronger free cash flow (2.3B), providing more financial flexibility.

Bottom Line

MDT scores higher overall (58/100 vs 48/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medtronic PLC

HEALTHCARE · MEDICAL DEVICES · USA

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.

Talen Energy Corporation

UTILITIES · UTILITIES - INDEPENDENT POWER PRODUCERS · USA

Talen Energy Corporation (Ticker: TLN) is a leading power generation and infrastructure company based in the United States, specializing in the development and operation of reliable and sustainable energy solutions. With a diverse portfolio that includes both traditional and renewable energy sources, Talen Energy is committed to supporting the evolving energy landscape while prioritizing environmental stewardship. The company is strategically positioned to meet growing electricity demand, leverage technological advancements, and enhance grid resilience, making it an attractive investment opportunity for institutional investors focused on the energy sector's transformation.

Want to dig deeper into these stocks?